Advertisement

The Lung

  • Jeffrey E. Weiland
  • James E. Gadek
Chapter

Abstract

The respiratory tract is unique in its dual role in the maintenance of health and prevention of disease. In addition to its function in gas exchange, the respiratory tract serves an important role in the body’s first line of defense against environmental pollutants. Each day the lung is exposed to approximately 10,000 L of air containing large amounts of particulate matter and noxious gases. The manner in which the lung handles this burden influences the toxic injury it sustains and, to a great extent, the health of the entire body (54, 75, 131, 152).

Keywords

Alveolar Macrophage Migration Inhibition Factor Lower Respiratory Tract Epithelial Line Fluid Alveolar Structure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aharonson EF, Menkes H, Gurtner G, et al: Effect of respiratory airflow rate on removal of soluble vapors by the nose. J Appl Physiol 37:654, 1974.PubMedGoogle Scholar
  2. 2.
    Arnold J: Uber das Vorkommen lymphatischen Gewebes in den Lungen. Virchows Arch Pathol Anat 80:315, 1880.CrossRefGoogle Scholar
  3. 3.
    Babior BM: Oxygen-dependent microbial killing by phagocytes. N Engl J Med 298:659, 1978.PubMedCrossRefGoogle Scholar
  4. 4.
    Beam AG: Alpha1-antitrypsin deficiency: A biological enigma. Gut 19:470, 1978.CrossRefGoogle Scholar
  5. 5.
    Beatty K, Bieth J, Iravis J: Kinetics of association of serine proteinases with native and oxidized α1-protei-nase inhibitor and α1-antichymotrypsin. J Biol Chem 255:3931, 1980.PubMedGoogle Scholar
  6. 6.
    Bell DY, Haseman JA, Spock A, et al: Plasma proteins of the bronchoalveolar surface of the lungs of smokers and nonsmokers. Am Rev Respir Dis 124:72, 1981.PubMedGoogle Scholar
  7. 7.
    Bienenstock J, Johnston N, Perey DYE: Bronchial lymphoid tissue: Morphologic characteristics. Lab Invest 28:686, 1973.PubMedGoogle Scholar
  8. 8.
    Blake J: On the movement of mucus in the lung. J Biomech 8:179, 1975.PubMedCrossRefGoogle Scholar
  9. 9.
    Bowes D, Corrin B: Ultrastructural immunocyto-chemical localization of lysozyme in human bronchial glands. Thorax 32:163, 1977.PubMedCrossRefGoogle Scholar
  10. 10.
    Brain JD, Golde DW, Green GW, et al: Biologic potential of pulmonary macrophages. Am Rev Respir Dis 118:435, 1978.PubMedGoogle Scholar
  11. 11.
    Brandtzaeg P: Mucosal and glandular distribution of immunological components: Differential localization of free and bound SC in secretory epithelial cells. J Immunol 112:1553, 1974.PubMedGoogle Scholar
  12. 12.
    Breeze RG, Wheeldon EB: The cells of the pulmonary airways. Am Rev Respir Dis 116:705, 1977.PubMedGoogle Scholar
  13. 13.
    Brundelet PJ: Experimental study of the dust clearance mechanism of the lung. Acta Pathol Microbiol Scand 175:1, 1965.Google Scholar
  14. 14.
    Camner P: Clearance of particles from the human trachiobronchial tree. Clin Sci 59:79, 1980.PubMedGoogle Scholar
  15. 15.
    Camner P, Philipson K, Arvidsson T: Withdrawal of cigarette smoking: A study on tracheobronchial clearance. Arch Environ Health 26:90, 1973.PubMedCrossRefGoogle Scholar
  16. 16.
    Cantin AM, North SL, Hubbard RC, et al: Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 63:152, 1987.PubMedGoogle Scholar
  17. 17.
    Carp H, Janoff A, Harel S: Inactivation of human bronchial mucous inhibitor (BMPi) by cigarette smoke. Am Rev Respir Dis 121:227, 1980.Google Scholar
  18. 18.
    Cerottini JC, Brunner KT: Cell mediated cytotoxicity, allograft rejection and tumor immunity. Adv Immunol 18:67, 1974.PubMedCrossRefGoogle Scholar
  19. 19.
    Chow CK: Biochemical responses in lung of ozone-tolerant rats. Nature 260:721, 1976.PubMedCrossRefGoogle Scholar
  20. 20.
    Chow CK, Tappel AL: Activities of pentose shunt and glycolytic enzymes in lungs of ozone exposed rats. Arch Environ Health 26:205, 1973.PubMedCrossRefGoogle Scholar
  21. 21.
    Coffin DL: Influence of ozone on pulmonary cells. Arch Environ Health 16:633, 1968.PubMedCrossRefGoogle Scholar
  22. 22.
    Cohen GM: Pulmonary metabolism of foreign compounds: Its role in metabolic activation. Environ Health Perspect 85:31, 1990.PubMedCrossRefGoogle Scholar
  23. 23.
    Cohen S, Pick E, Oppenheim JJ (Eds.): Biology of the Lymphokines, Academic Press, New York, 1979.Google Scholar
  24. 24.
    Committee on Diagnostic Standards for Nontubercu-lous Respiratory Disease: Chronic bronchitis, asthma, and pulmonary emphysema: Statement of the American Thoracic Society. Am Rev Respir Dis 85:762, 1962.Google Scholar
  25. 25.
    Cong H, Drage CW(eds.): The Respiratory System: A Core Curriculum, Appleton-Century-Crofts, New York, 1982.Google Scholar
  26. 26.
    Cranfield LM, Gollan JL, White AG, et al: Serum antioxidant activity in normal and abnormal subjects. Ann Clin Biochem 16:299, 1979.PubMedGoogle Scholar
  27. 27.
    Crapo JD: Tierney DF: Superoxide dismutase and pulmonary oxygen toxicity. Am J Physiol 226:1401, 1974.PubMedGoogle Scholar
  28. 28.
    Crapo JD, Sjostrom K, Drew RT: Tolerance and cross-tolerance using NO2 and O2. I. Toxicology and biochemistry. J Appl Physiol 44:364, 1978.PubMedGoogle Scholar
  29. 29.
    Dalhamm T: Mucous flow and ciliary activity in the trachea of healthy rats exposed to respiratory irritant gases (SO2, NH3, HCHO). Acta Physiol Scand 36:1, 1956.CrossRefGoogle Scholar
  30. 30.
    Dalhamm T: Studies on the effect of sulfur dioxide on ciliary activity in rabbit trachea in vivo and in vitro and on the resorptional capacity of the nasal cavity. Am Rev Respir Dis 83:566, 1961.Google Scholar
  31. 31.
    Daniele RP, Dauber JH, Altose MD, et al: Lymphocyte studies in asymptomatic cigarette smokers. Am Rev Respir Dis 116:997, 1977.PubMedGoogle Scholar
  32. 32.
    Dawson CA, Braley JF, Moore VL: Influence of immunity on the absorption of inhaled antigen. Chest 75 (Suppl):276, 1979.PubMedGoogle Scholar
  33. 33.
    Duncan CA: Lung metabolism of xenobiotic compounds. Clin Chest Med 10:49, 1989.PubMedGoogle Scholar
  34. 34.
    Finklea J, Hasselblad V, Riggan WB, et al: Cigarette smoking and hemagglutination inhibition response to influenza after natural disease and immunization. Am Rev Respir Dis 104:368, 1971.PubMedGoogle Scholar
  35. 35.
    Fong KL, McCay PB, Poyer JL: Evidence that peroxidation of lysozomal membranes is initiated by hy-droxyl free radicals produced during flavin enzyme activity. J Biol Chem 248:7792, 1973.PubMedGoogle Scholar
  36. 36.
    Frank L, Bucher JR, Roberts RJ: Oxygen toxicity in neonatal and adult animals of various species. J Appl Physiol 45:699, 1979.Google Scholar
  37. 37.
    Fridovich I: The biology of oxygen radicals. Science 201:875, 1978.PubMedCrossRefGoogle Scholar
  38. 38.
    Fridovich I, Freeman B: Antioxidant defenses in the lung. Annu Rev Physiol 48:693, 1986.PubMedCrossRefGoogle Scholar
  39. 39.
    Gadek JE, Fells GA, Crystal RG: Cigarette smoking induces functional antiprotease deficiency in the lower respiratory tract in humans. Science 206:1315, 1979.PubMedCrossRefGoogle Scholar
  40. 40.
    Gadek JE, Fells GA, Wright DG, et al: Neutrophil elastase functions as a type III collagenase. Biochem Biophys Res Commun 95:1818, 1980.CrossRefGoogle Scholar
  41. 41.
    Gadek JE, Hunninghake GW, Fells GA, et al: Evaluation of the protease-antiprotease theory of human destructive lung disease. Bull Eur Physiopathol Respir 16:27, 1980.PubMedGoogle Scholar
  42. 42.
    Gadek JE, Fells GA, Zimmerman RL, et al: Anti-elastases of the human alveolar structures. J Clin Invest 68:889, 1981.PubMedCrossRefGoogle Scholar
  43. 43.
    Galdston M, Levytska V, Schwartz MS, et al: Ceru-loplasmin. Am Rev Respir Dis 129:258, 1984.Google Scholar
  44. 44.
    Gardner DE, Holzman RS, Coffin DL: Effect of nitrogen dioxide on pulmonary cell population. J Bacteriol 98:1048, 1969.Google Scholar
  45. 45.
    Gardner DE, Pfitzer EA, Christian RT, et al: Loss of protective factor for alveolar macrophages when exposed to ozone. Arch Intern Med 127:1078, 1971.PubMedCrossRefGoogle Scholar
  46. 46.
    Golde DW, Finley TN, Cline MJ: The pulmonary macrophage in acute leukemia. N Engl J Med 290: 875, 1974.PubMedCrossRefGoogle Scholar
  47. 47.
    Gordon RE, Case BW, Kleinerman J; Acute NO2 effects on penetration and transport of horseradish peroxidase in hamster respiratory epithelium. Am Rev Respir Dis 128:528, 1983.PubMedGoogle Scholar
  48. 48.
    Gram TE, Okine LK, Gram RA: The metabolism of xenobiotics by certain extrahepatic organs and its relationship to toxicity. Annu Rev Pharmacol Toxicol 26:259, 1986.PubMedCrossRefGoogle Scholar
  49. 49.
    Green GM: Alveolo-bronchiolar transport: Observations and hypothesis of a pathway. Chest 59(Suppl): IS, 1971.Google Scholar
  50. 50.
    Green GM: Alveolobronchiolar transport mechanisms. Arch Intern Med 131:109, 1973.PubMedCrossRefGoogle Scholar
  51. 51.
    Green GM, Carolin D: The depressant effect of cigarette smoke on the in vitro antibacterial activity of alveolar macrophages. N Engl J Med 276:422, 1967.CrossRefGoogle Scholar
  52. 52.
    Green GM, Jakab GJ, Low RB, et al: Defense mechanisms of the respiratory membrane. Am Rev Respir Dis 115:479, 1977.PubMedGoogle Scholar
  53. 53.
    Harris CC, Hsu IC, Stoner GD: Human pulmonary alveoli macrophages metabolize benzo[a]pyrene to proximate and ultimate mutagens. Nature 272:633, 1978.PubMedCrossRefGoogle Scholar
  54. 54.
    Heffner JE, Repine JE: Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 140:531, 1989.PubMedCrossRefGoogle Scholar
  55. 55.
    Hochstrasser K, Teichert R, Schwarz S, et al: Isolierung und Charakterisierung eines Proteasen-inhibitors aus dem menschlichen bronchial Sekret. Hoppe-Seylers Z Physiol Chem 353:221, 1972.PubMedCrossRefGoogle Scholar
  56. 56.
    Hoidal JR, Fox RB, LeMarbe PA, et al: Altered oxidative metabolic response in vitro of alveolar macrophages from asymptomatic smokers. Am Rev Respir Dis 123:85, 1981.PubMedGoogle Scholar
  57. 57.
    Holt PG, Finlay-Jones LM, Keast D, et al: Immunological function in mice chronically exposed to nitrogen oxides (NCy. Environ Res 19:154, 1979.PubMedCrossRefGoogle Scholar
  58. 58.
    Horwitt MK: Vitamin E. A reexamination. Am J Clin Nutr 29:569, 1976.Google Scholar
  59. 59.
    Hunninghake GW, Crystal RG: Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. J Clin Invest 67:86, 1981.PubMedCrossRefGoogle Scholar
  60. 60.
    Hunninghake GW, Crystal RG: Cigarette smoking and lung destruction. Am Rev Respir Dis 128:833, 1983.PubMedGoogle Scholar
  61. 61.
    Hunninghake GW, Gadek JE, Kawanami O, et al: Inflammatory and immune processes in the human lung in health and disease: Evaluation by bron-choalveolar lavage. Am J Pathol 7:149, 1979.Google Scholar
  62. 62.
    Hunninghake GW, Gadek JE, Fales HM, et al: Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization. J Clin Invest 66:473, 1980.PubMedCrossRefGoogle Scholar
  63. 63.
    Hunninghake GW, Gadek JE, Young RC, et al: Maintenance of granuloma formation in pulmonary sarcoidosis by T-lymphocytes within the lung. N Engl J Med 302:594, 1980.PubMedCrossRefGoogle Scholar
  64. 64.
    Hurst DJ, Coffin DL: Ozone effect on lysosomal hydrolases of alveolar macrophages. Arch Intern Med 127:1059, 1971.PubMedCrossRefGoogle Scholar
  65. 65.
    Hurst DJ, Gardner DE, Coffin DL: Effect of ozone on acid hydrolases of the pulmonary alveolar macrophage. Res J Reticuloendothel Soc 8:288, 1970.Google Scholar
  66. 66.
    Iravani J, Melville GN: Mucociliary function in the respiratory tract as influenced by physiochemical factors. Pharmacol Ther 2:471, 1976(B).Google Scholar
  67. 67.
    Janoff A, Carp H: Possible mechanisms of emphysema in smokers. Cigarette smoke condensate suppresses protease inhibitor in vitro. Am Rev Respir Dis 116:65, 1977.PubMedGoogle Scholar
  68. 68.
    Janoff A, White R, Caro H, et al: Lung injury induced by leukocytic proteases. Am J Pathol 97:111, 1979.PubMedGoogle Scholar
  69. 69.
    Jeffrey PK: The respiratory mucous membrane. In: Respiratory Defense Mechanisms, Part I, p 193, Brain JD (ed.), Marcel Dekker, New York, 1977.Google Scholar
  70. 70.
    Johnson DA: Ozone inactivation of human α1-proteinase inhibitor. Am Rev Respir Dis 121:1031, 1980.PubMedGoogle Scholar
  71. 71.
    Johnson DA, Travis J:Human alpha I-antiproteinase inhibitor mechanism of action: Evidence for activation by limited proteolysis. Biochem Biophys Res Commun 72:33, 1976.PubMedCrossRefGoogle Scholar
  72. 72.
    Johnson D, Travis J: Structural evidence for methionine at the reactive site of human α1-proteinase inhibitor. J Biol Chem 253:7142, 1978.PubMedGoogle Scholar
  73. 73.
    Johnston JR, Keele BB Jr, Misra HP, et al: The role of superoxide anion generation in phagocytic bactericidal activity. J Clin Invest 55:1357, 1975.PubMedCrossRefGoogle Scholar
  74. 74.
    Jurgensen PF, Olsen GN, Johnson JE 3rd, et al: Immune response of the human respiratory tract II. Cell mediated immunity in the lower respiratory tract to tuberculin and mumps and influenza viruses. J Infect Dis 128:730, 1973.PubMedCrossRefGoogle Scholar
  75. 75.
    Kaltreider HB: Expression of immune mechanisms in the lung. Am Rev Respir Dis 113:347, 1976.PubMedGoogle Scholar
  76. 76.
    Kaltreider HB: Phagocytic, antibody and cell-mediated immune mechanisms. In: Textbook of Respiratory Medicine, p 322, Murray JF, Nadel JA (eds.), WB Saunders, Philadelphia, 1988.Google Scholar
  77. 77.
    Karlinsky JB, Snider GL: Animal models of emphysema. Am Rev Respir Dis 117:1109, 1978.PubMedGoogle Scholar
  78. 78.
    Kennedy SM, Elwood RK, Wiggs BJR, et al: Increased airway mucosal permeability of smokers. Am Rev Respir Dis 129:143, 1984.PubMedGoogle Scholar
  79. 79.
    Kimball RE, Reddy K, Peirce TH, et al: Oxygen toxicity: Augmentation of antioxidant defense mechanisms in rat lung. Am J Physiol 230:1425, 1976.PubMedGoogle Scholar
  80. 80.
    King M, Gilboa A, Meyer A, et al: On the transport of mucus and its rheologic simulants in ciliated systems. Am Rev Respir Dis 110:740, 1974.PubMedGoogle Scholar
  81. 81.
    Klebanoff SJ, Clark RA: The Neutrophil: Function and Clinical Disorders, Elsevior/North-Holland, Amsterdam, 1978.Google Scholar
  82. 82.
    Kuhn C, Senior RM: The role of elastases in the development of emphysema. Lung 155:461, 1977.Google Scholar
  83. 83.
    Lamb D, Reid L: Mitotic rates, goblet cell increase and histochemical changes in mucus in rat bronchial epithelium during exposure to SO2. J Pathol Bacteriol 96:97, 1968.PubMedCrossRefGoogle Scholar
  84. 84.
    Langevoort HC: The nomenclature of mononuclear phagocytic cells. In: Mononuclear Phagocytes, p 1, van Furth R (ed.), FA Davis, Philadelphia, 1970.Google Scholar
  85. 85.
    Laughter AH, Martin RR, Twomey JJ: Lymphopro-liferative responses to antigens mediated by human pulmonary alveolar macrophages. J Lab Clin Med 89:1326, 1977.PubMedGoogle Scholar
  86. 86.
    Lauweryns JM, Boussauw L: The ultrastructure of pulmonary lymphatic capillaries in newborn rabbits and human infants. Lymphology 1:108, 1968.Google Scholar
  87. 87.
    Lawrence EC, Blaese RM, Martin RR, et al: Immunoglobulin secreting cells in normal human bronchial lavage fluids. J Clin Invest 62:832, 1978.PubMedCrossRefGoogle Scholar
  88. 88.
    Lawther JPL: Air pollution and tobacco smoke. In: Clinical Aspects of Inhaled Particles, Muir DCF (ed.), p 21, Heineman, London, 1972.Google Scholar
  89. 89.
    Lieberman J: Elastase, collagenase, emphysema and alpha I-antitrypsin deficiency. Chest 70:62, 1976.PubMedCrossRefGoogle Scholar
  90. 90.
    Little C, Olinescu R, Reid KG, et al: Properties and regulation of glutathione peroxidase. J Biol Chem 254:3632, 1970.Google Scholar
  91. 91.
    Lourenco RV, Klimer MF, Borowski CJ: Deposition and clearance of 2 particles in the tracheobronchial tree of normal subjects: Smokers and nonsmokers. J Clin Invest 50:1411, 1971.PubMedCrossRefGoogle Scholar
  92. 92.
    Low RB: Effects of acrolein on in vitro protein biosynthesis and substrate transport by rabbit pulmonary alveolar macrophages. Am Rev Respir Dis 111: 924, 1975.Google Scholar
  93. 93.
    Lucas AM, Douglas LC: Principles underlying ciliary activity in the respiratory tract. Arch Otolaryngol 20: 518, 1934.CrossRefGoogle Scholar
  94. 94.
    Lucy JA: Functional and structural aspects of biological membranes: A suggested structural role for vitamin E in the control of membrane permeability and stability. Ann NY Acad Sci 204:4, 1972.CrossRefGoogle Scholar
  95. 95.
    MacNee W, Wiggs B, Belzberg AS, et al: The effect of cigarette smoking on neutrophil kinetics in human lungs. N Engl J Med 321:924, 1989.PubMedCrossRefGoogle Scholar
  96. 96.
    Martin D, Jacobi W: Diffusion of small-sized particles in the bronchial tree. Health Phys 23:23, 1972.PubMedCrossRefGoogle Scholar
  97. 97.
    Mason RJ: Metabolism of alveolar macrophages. In: Respiratory Defense Mechanisms, p 893, Brain JD, Proctor DF, Reid LM (eds.), Marcel Dekker, New York, 1977.Google Scholar
  98. 98.
    McCay PB, Gibson DD, Fong KL, et al: Effect of glutathione peroxidase activity on lipid peroxidation in biological membranes. Biochim Biophys Acta 431: 459, 1976.CrossRefGoogle Scholar
  99. 99.
    McDermott MR, Bienenstock J: Evidence of a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J Immunol 122:1982, 1979.Google Scholar
  100. 100.
    Mead J, Turner JM, Macklem PT, et al: Significance of the relationship between lung recoil and maximum expiratory flow. J Appl Physiol 22:95, 1967.PubMedGoogle Scholar
  101. 101.
    Merrill WW, Goodenberger D, Strober W, et al: Free secretory component and other proteins in human lung lavage. Am Rev Respir Dis 122:156, 1980.PubMedGoogle Scholar
  102. 102.
    Miller S, Ehrlich R: Susceptibility to respiratory infections of animals exposed to ozone. J Infect Dis 103: 145, 1958.PubMedCrossRefGoogle Scholar
  103. 103.
    Morgan TE: Pulmonary surfactant. N Engl J Med 284:1185, 1971.PubMedCrossRefGoogle Scholar
  104. 104.
    Nakajima K, Powers JC, Ashe BM, et al: Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. J Biol Chem 254:4027, 1979.PubMedGoogle Scholar
  105. 105.
    Nathan CF, Karnovsky ML, David JR: Alterations of macrophage functions by mediators from lymphocytes. J Exp Med 133:1356, 1971.PubMedCrossRefGoogle Scholar
  106. 106.
    National Research Council: Atmospheric Ozone Studies, National Academy of Sciences, Washington, 1966.Google Scholar
  107. 107.
    Negus VE: Function of mucus. Acta Otolaryngol (Stockh) 56:204, 1963.CrossRefGoogle Scholar
  108. 108.
    Olsen GN, Harris JO, Castle JR, et al: Alpha I-anti-trypsin content in the serum alveolar macrophages and alveolar lavage fluid of smoking and non-smoking normal subjects. J Clin Invest 55:427, 1975.PubMedCrossRefGoogle Scholar
  109. 109.
    Pacht ER, Kaseki H, Mohammed JR, et al: Deficiency of vitamin E in the alveolar fluid of cigarette smokers: Influence on alveolar macrophage cytotoxicity. J Clin Invest 77:786, 1986.Google Scholar
  110. 110.
    Patriarca P, Dri P, Rossi F: Superoxide dismutase in leukocytes. FEBS Lett 43:247, 1974.PubMedCrossRefGoogle Scholar
  111. 111.
    Phipps RJ: The airway mucociliary system. In: Respiratory Physiology III, p 215, Widdicombe JG (ed.), University Park Press, Baltimore, 1981.Google Scholar
  112. 112.
    Purvis MR, Miller S, Ehrlich R: Effect of atmospheric pollutants on susceptibility to respiratory infections. J Infect Dis 109:238, 1961.PubMedCrossRefGoogle Scholar
  113. 113.
    Racz P, Tenner-Tacz K, Myrvik QN, et al: Functional architecture: Bronchial associated lymphoid tissue and lymphoepithelium in pulmonary cell mediated reactions in the rabbit. J Reticuloendothel Soc 22:59, 1977.PubMedGoogle Scholar
  114. 114.
    Ranga V, Kleinerman J, Collins AM: The effect of nitrogen dioxide on tracheal uptake and transport of horseradish peroxidase in the guinea pig. Am Rev Respir Dis 122:438, 1980.Google Scholar
  115. 115.
    Reynolds HY, Atkinson JP, Newball HH, et al: Receptors for immunoglobulin and complement on human alveolar macrophages. J Immunol 114:1813, 1975.PubMedGoogle Scholar
  116. 116.
    Reynolds HY, Newball HH: Analysis of proteins and respiratory cells obtained from human lungs by bronchoalveolar lavage. J Lab Clin Med 84:559, 1974.PubMedGoogle Scholar
  117. 117.
    Reynolds HY, Newball HH: Fluid and cellular milieu of the human respiratory tract. In: Immunologic and Infectious Reactions in the Lung, Vol 1, p 3, Kirk-patrick CH, Reynolds HY (eds.), Marcel Dekker, New York, 1976.Google Scholar
  118. 118.
    Reynolds HY, Thompson RE: Pulmonary host defenses. II. Interaction of respiratory antibodies with Pseudomonas aeruginosa and alveolar macrophages. J Immunol 111:369, 1973.PubMedGoogle Scholar
  119. 119.
    Robertson J, Caldwell JR, Castle JR, et al: Evidence for the presence of components of the alternative (properidim) pathway of complement activation in respiratory secretions. J Immunol 117:900, 1976.PubMedGoogle Scholar
  120. 120.
    Rodriquez RJ, White RR, Senior RM, et al: Elastase release from human alveolar macrophages: Comparison between smokers and nonsmokers. Science 198: 313, 1977.CrossRefGoogle Scholar
  121. 121.
    Rudzik O, Clancy RL, Perey DYE, et al: The distribution of a rabbit thymic antigen and membrane immunoglobulins in lymphoid tissue, with special reference to mucosal lymphocytes. J Immunol 114:1, 1975.PubMedGoogle Scholar
  122. 122.
    Serafini SM, Wanner A, Michaelson ED: Mucociliary transport in central and intermediate size airways: Effect of aminophylline. Bull Eur Physiopathol Respir 12:415, 1976.PubMedGoogle Scholar
  123. 123.
    Skornik WA, Brain JD: Relative toxicity of inhaled metal sulfate salts for pulmonary macrophages. Am Rev Respir Dis 128:297, 1983.PubMedGoogle Scholar
  124. 124.
    Smith KA, Gillis S, Baker PE, et al: T-cell growth factor mediated T-cell proliferation. Ann NY Acad Sci 332:423, 1979.PubMedCrossRefGoogle Scholar
  125. 125.
    Smith LL: The response of the lungs to foreign compounds that produce free radicals. Annu Rev Physiol 48:681, 1986.PubMedCrossRefGoogle Scholar
  126. 126.
    Sorokin SP, Brain JD: Pathways of clearance in mouse lungs exposed to iron oxide aerosols. Anat Rec 181: 581, 1975.PubMedCrossRefGoogle Scholar
  127. 127.
    Spicer SS, Frayser R, Virella G, et al: Immunocyto-chemical localization of lysozyme in respiratory and other tissues. Lab Invest 36:282, 1977.PubMedGoogle Scholar
  128. 128.
    Starkey PM, Barrett AJ: α2-Macroglobulin, a physiologic regulator of proteinase activity. In: Proteinases in Mammalian Cells and Tissues, p 663, Barret AJ (ed.), Elsevier/North-Holland, Amsterdam, 1977.Google Scholar
  129. 129.
    Stossel TP: Phagocytosis: Recognition and ingestion. Semin Hematol 12:83, 1975.PubMedGoogle Scholar
  130. 130.
    Stossel TP, Hartwig JH: Interactions of actin, myosin and new actin-binding protein of rabbit pulmonary macrophages II. Role in cytoplasmic movement and phagocytosis. J Cell Biol 68:602, 1976.PubMedCrossRefGoogle Scholar
  131. 131.
    Symposium on chemicals and lung toxicity—to study the agent or the disease. Environ Health Per-spect 85:3–331, 1990.Google Scholar
  132. 132.
    Tappel AL: Vitamin E. Nutrition Today 8:4, 1973.CrossRefGoogle Scholar
  133. 133.
    Task Group on Lung Dynamics: Deposition and retention models for internal dosimetry of the human respiratory tract. Health Phys 12:179, 1966.Google Scholar
  134. 134.
    Tegener H: Quantitation of human granulocyte protease inhibitors in non-purulent bronchial lavage fluids. Acta Otolaryngol 85:282, 1978.Google Scholar
  135. 135.
    Tegner H, Ohlsson K: Localization of a low molecular weight protease inhibitor to tracheal and maxillary sinus mucosa. In: Neutral Proteases of Human Polymorphonuclear Leukocytes, p 208, Havemann K, Janoff A (eds.), Urban & Schwarzenberg, Baltimore, 1978.Google Scholar
  136. 136.
    Thomas ED, Ramberg RE, Sale GE: Direct evidence for a bone marrow origin of the alveolar macrophage. Science 192:1016, 1976.PubMedCrossRefGoogle Scholar
  137. 137.
    Thomas WR, Holt PG, Keast D: Cellular immunity in mice chronically exposed to fresh cigarette smoke. Arch Environ Health 27:372, 1973.PubMedCrossRefGoogle Scholar
  138. 138.
    Thomas WR, Holt PG, Keast D: Effect of cigarette smoking on primary and secondary responses in mice. Nature 243:240, 1973.PubMedCrossRefGoogle Scholar
  139. 139.
    Thomas WR, Holt PG, Keast D: Humoral immune response of mice chronically exposed to fresh cigarette smoke. Arch Environ Health 30:78, 1975.PubMedCrossRefGoogle Scholar
  140. 140.
    Thomasi TB, Grey HM: Structure and function of immunoglobulin A. Prog Allergy 16:81, 1972.Google Scholar
  141. 141.
    Ulrich F: Studies of lymphocyte activating factor from alveolar macrophages. Res J Reticuloendothel Soc 21: 33, 1977.Google Scholar
  142. 142.
    US Public Health Service: The Health Consequences of Involuntary Smoking. A Report of the Surgeon General, Department of Health and Human Services, Washington, 1986.Google Scholar
  143. 143.
    Vai F, Fournier MF, LaFuma JC, et al: SO2-induced bronchopathy in the rat: Abnormal permeability of the bronchial epithelium in vivo and in vitro after anatomic recovery. Am Rev Respir Dis 121:851, 1980.PubMedGoogle Scholar
  144. 144.
    Valand SB, Acton JP, Myrvik QN: Nitrogen dioxide inhibition of viral-induced resistance in alveolar monocytes. Arch Environ Health 20:303, 1970.PubMedCrossRefGoogle Scholar
  145. 145.
    Vassallo CL, Domm BM, Poe RH, et al: NO2 gas and NPOeffects on alveolar macrophage phagocytosis and metabolism. Arch Environ Health 26:270, 1973.PubMedCrossRefGoogle Scholar
  146. 146.
    Waldman RH, Ganguly R: The role of the secretory immune system in protection against agents which infect the respiratory tract. Adv Exp Med Biol 45:283, 1974.PubMedGoogle Scholar
  147. 147.
    Wanner A: Clinical aspects of mucociliary transport. Am Rev Respir Dis 116:73, 1977.PubMedGoogle Scholar
  148. 148.
    Warr GA, Martin RR: In vitro migration of human alveolar macrophages: Effects of cigarette smoking. Infect Immun 8:222, 1973.PubMedGoogle Scholar
  149. 149.
    Warr GA, Martin RR: Chemotactic responsiveness of human alveolar macrophages: Effects of cigarette smoking. Infect Immun 9:769, 1974.PubMedGoogle Scholar
  150. 150.
    Warr GA, Martin RR, Holleman C, et al: Classification of bronchial lymphocytes from non-smokers and smokers. Am Rev Respir Dis 113:96, 1976.PubMedGoogle Scholar
  151. 151.
    West JB: Observation on gas flow in the human bronchial tree. In: Inhaled Particles and Vapours, p. 3, Davies CN (ed.), Pergamon Press, New York, 1961.Google Scholar
  152. 152.
    Witschi DH: Responses of the lung to toxic injury. Environ Health Perspect 85:5, 1990.PubMedCrossRefGoogle Scholar
  153. 153.
    Yam J, Frank L, Roberts RJ: Oxygen toxicity: Comparison of lung biochemical responses in neonatal and adult rats. Pediatr Res 12:115, 1978.PubMedCrossRefGoogle Scholar
  154. 154.
    Zarkower A: Alterations in antibody response induced by chronic inhalation of SO2 and carbon. Arch Environ Health 25:45, 1972.PubMedCrossRefGoogle Scholar

Recommended Readings

  1. Heffner JE, Repine JE: Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 140:531, 1989.PubMedCrossRefGoogle Scholar
  2. Kaltreider HB: Phagocytic, antibody and cell-mediated immune mechanisms. In: Textbook of Respiratory Medicine, p 332, Murray JF, Nadel JA (eds.), WB Saunders, Philadelphia, 1988.Google Scholar
  3. Symposium on Chemicals and Lung Toxicity—To study the agent or the disease. Environ Health Perspect 85: 3–331, 1990.Google Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Jeffrey E. Weiland
  • James E. Gadek

There are no affiliations available

Personalised recommendations